You are invited to participate in an exclusive Catalyst Society Video Conference with a member of the Cure Alzheimerās FundĀ Research Consortium. David Michael Holtzman, M.D.Ā will share new insights about the disease pathologyĀ and the opportunities and challenges facing the Alzheimerās scientific research community. The presentation will be followed by a Q&A. If we ...
May 4, 2017
As you cross the Sagamore Bridge over the Cape Cod Canal, heading to the mainland, the view to the starboard is startling in its natural beauty, its expanse of sapphire shoreline, and soul-searching mood for deep reflection. On an incoming ocean tide, the roiling waters of the canal spill out ...
February 26, 2023
Cure Alzheimerās Fund will host Dr. David Holtzman for a live webinar on Thursday, May 27 at 5:30 PM.Ā Diagnosing Alzheimerās Disease: A Groundbreaking New Blood Test is free and open to the public. Registration is required. Dr. Holtzman is a co-inventor of a new blood test, PrecivityAD, designed to assist ...
May 20, 2021
Cure Alzheimer’s Fund is pleased to see the passage of the 21st Centuries Cures Act in the House of Representatives. The overwhelming bipartisan support for the bill shows the need for legislation to improve the process of getting to cures for life-threatening diseases like Alzheimer’s. The legislation calls for increased investment ...
July 10, 2015
From the author, “This book holds a special place in my heart because the situations described within are all derived from instances that we went through with my Granny, and the stories that she would tell us of her childhood when that was all that she could remember anymore. Of ...
June 26, 2023
A NYT article about the value of using spinal fluid tests to determine the presence of Alzheimerās disease is optimistic and hopeful but maybe too much so. In an article published yesterday, Gina Kolata writes āResearchers are finding simple and accurate ways to detect Alzheimerās long before there are definite ...
August 11, 2010
Prof. Eran Elinav, M.D., Ph.D. is a professor heading the Department of Systems Immunology, Weizmann Institute of Science, Israel, and the director of the Microbiome & Cancer division, National German Cancer Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany. His labs at the Weizmann Institute and DKFZ focus on deciphering the molecular ...
April 19, 2023
Growing evidence has implicated a critical role for microglia in mediating Alzheimerās disease (AD) pathogenesis, making them a promising target for AD therapeutics. Impaired microglial phagocytosis results in accumulation of amyloid beta (AĪ²), leading to neuroinflammation, which is the primary driver of neurodegeneration. Through an unbiased high-throughput screen of a ...
October 25, 2023
The Fund Continues to Support Research Resulting in Significant Breakthroughs Toward a Cure Through Studying the Mechanisms and Treatment of, and Prevention Strategies for, Alzheimerās Disease WELLESLEY, Mass. ā Dec. 11, 2019 ā Ā Cure Alzheimerās Fund, a non-profit dedicated to funding research with the highest probability of preventing, slowing, or reversing ...
December 12, 2019
Dearest Family and Friends, It is with heavy, but relieved, hearts that we tell you our beloved Ron, age 78, transitioned peacefully and joyfully from our home into Godās arms on March 14, 2021, due to complications of Alzheimerās disease. How appropriate that he took his last breath on a Sunday ...
April 12, 2021
